PHA Classroom: e-Learning. Anytime. Anyplace.

>> Back to Recordings

PH Treatments: What’s on the Horizon

February 1, 2011

It is an exciting time for PAH research. Over the past 13 years, eight PAH therapies have been approved by the FDA! In this session, learn about the new treatments available and treatments currently in the pipeline. Learn more about PAH treatments

Watch Event Recording

If the below recording does not begin automatically, click the arrow. Click Fullscreen button Full screen icon in interface below to watch recording in your full screen. To view the controls, move your mouse anywhere over the video then move to the control interface at the bottom of the video. Please note, you will not need an access code; those directions, if mentioned, are for live event participants. 

   

Presenter Information

Michael McGoon, MD

Michael D. McGoon, MD
Mayo Clinic, Rochester

Dr. McGoon is a consultant in the Division of Cardiovascular Diseases at the Mayo Clinic and Professor of Medicine at the Mayo Clinic College of Medicine. After attending medical school at Johns Hopkins, he completed subspecialty cardiology training at Mayo and has been on staff there since 1983. Dr. McGoon is currently on PHA’s Board of Trustees and is a member of PHA’s Scientific Leadership Council.

>>If you liked this recording, you may enjoy Guinea Pig or Hero: The Journey Through Clinical Trials

Guinea Pig or Hero: The Journey Through Clinical Trials

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2014 Pulmonary Hypertension Association. All Rights Reserved.

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.